BioSurfaces, an Ashland, MA-based provider of the Bio-Spun™ Cell Chamber (BSCC) device, received a $2.0m grant from Bill and Melinda Gates Foundation.
The company intends to use the funds to increase cell capacity of the BSCC device.
Led by CEO and President Matthew Phaneuf, BioSurfaces is focused on improving lives throughout the world by applying its Bio-Spun™ nanofiber materials paired with expertise to develop and provide a range of products and solutions with synthetic cellular matrices.
The Bio-Spun™ Cell Chamber (BSCC) is an innovative device designed to provide long-term delivery of a biotherapeutic agent to treat a chronic illness. The BSCC device encapsulates genetically engineered cells that produce therapeutic proteins. Based on its extensive pre-clinical research on the BSCC, BioSurfaces expects the research funded by the grant to demonstrate that the BSCC can achieve the three key, and very challenging, goals of implantable cell therapy delivery devices: enabling cells to receive nutrients from the body, protecting the cells from attack from the immune system and allowing the biotherapeutic agent produced by the cells to move from the device into the body.
FinSMEs
25/11/2024